New Venture Creation 2: Launching a spin-out company 18 - 20 March 2020

User login

You need to log in to register for events

Is this course right for me?

  • This course is for knowledge transfer professionals with at least 18 months’ technology transfer experience gained in an academic, public sector research or NHS innovation environment
  • A working knowledge of contracts and IP management will be assumed
  • It enables delegates to develop practical skills in scrutinising a business plan, understanding the different sources of finance available, critiquing and mentoring pitching. It will enable delegates to understand the key terminology in new venture creation, including term sheet and their consequences understanding the basics of company valuation, the role of directors, supporting the company post-incorporation. So, it’s likely to be of most value for those who are developing their case management skills and looking to embrace this aspect of KT
  • Those who have attended a PraxisAuril ‘core’ course (e.g. Fundamentals of Technology Transfer or Research Contracts) might find this to be a valuable next step, especially if they are seeking to develop practical hand-on skills in how to determine whether projects are suitable for new company formation and how to start a new company
  • Delegates might have significant experience in TT/KT, but little practical experience of new venture formation and may be looking to kick start this activity in their institution

Why should I attend this course?

  • Company creation is a key element in the mix of instruments that allow Universities to deliver impact from their funding inputs and research outputs
  • Forming new companies can be a key enabler of developing new technologies and priming them for the market place, and a key tool for the knowledge transfer professional
  • It can facilitate economic benefits including a financial return to inventors and their institutions whilst creating new jobs and services of benefit to the local economy and beyond
  • New ventures may enjoy symbiotic relationships with their parent institutions investing in further University research and securing rights to develop arising IP
  • There is increasing expectation that Universities and research institutes should be skilled at setting up actively managing their relationships with new ventures companies
  • Creating new ventures is a complex, challenging and immersive experience. This course gives a framework for knowing how to embrace this exciting challenge

What will I learn from the course?

  • Define what success in new venture creation looks like from a range of stakeholder perspectives
  • It looks at how to scrutinise and develop opportunities to investment readiness and beyond
  • It explores basic company valuation and the key terminology in new venture creation, including term sheet and their consequences
  • It explores how to develop a pitch to gain investment

Delegates will have the opportunity to hear from academic, technology transfer practitioners with experience in company formation, lawyers and venture capital investors. There will also be ample opportunity for networking with other delegates, the course team and other contributors.

PLEASE NOTE: There may be a requirement for delegates to undertake some pre-course work/reading before the course begins.

What makes this course different to others available in the sector?

PraxisAuril is able to deliver this training from the unique perspective of KE practitioners. We see the world from the same angle as you do!  We draw on a wide pool of experience and expertise from within the profession and build them into the course content, ensuring we are always delivering up to date, sector leading training and development.

The course has been updated in light of feedback from last time, to ensure that it continues to meet the needs of each of our delegates. The highly participative and interactive programme uses a new range of interactive techniques to engage delegates in an immersive, memorable and enjoyable learning experience.

View outline programme (subject to change)


The course fee includes:

  • Attendance at all lectures and workshops
  • Training and reference materials (electronic or otherwise)
  • Registration event (including buffet dinner & drinks*) on Wednesday 18 March 2020
  • Networking event (including buffet dinner & drinks*) on Thursday 19 March 2020
  • Morning and afternoon refreshments and lunch every day

* Please note that there is no reduction in the course fee if you choose not to attend the evening events.



The course will be held at Burleigh Court which is located on the Loughborough University campus (West Entrance). Loughborough railway station is three miles away - taxis are available at the station or there is a regular shuttle bus every 20 minutes from the station to the venue. If you are driving, Burleigh Court is one mile from junction 23 on the M1; ample free secure on-site car parking is available. Nottingham East Midlands Airport is just eight miles away.


Discounted bed and breakfast accommodation is available at Burleigh Court at £95.00 per night, per person. Please book your accommodation direct with Burleigh Court by calling 01509 633030 and quote the PraxisAuril event reference number 361742 in order to receive the discounted rate. Discounted rates are not available when booking accommodation online.  Any bedrooms that are not booked by Wednesday 19 February 2020 will be released. Accommodation may still be available at Burleigh Court after this date but might not be at the discounted rate.

Please note that the course begins with registration, including dinner and drinks, on Wednesday 18 March 2020 from 1830-2030.



12 ATTP Points

18th March - 20th March


Course Fee (Member Price - £965.00) £ 1295.00

Meet the Speakers/Trainers

Dr. Iain Thomas RTTP

Course Director
Head of Life Sciences, Cambridge Enterprise Ltd
Iain is Head of Cambridge Enterprise’s Life Sciences team at the University of Cambridge where he and his team work in fields as diverse as therapeutics, diagnostics, biofuels, IVF, epigenetics and agritech. CE’s portfolio of products includes alemtuzumab (Sanofi), breast cancer markers (Brevagen) and mouse touch screen chambers (Campden Instruments). Recent spin-outs include Morphogenix, Mission Therapeutics, Cambridge Epigenetix, XO1 Therapeutics (sold to Janssen), Z-factor, Phoremost, and Storm Therapeutics. Iain led discussions with GSK in respect of the University of Cambridge–GSK open innovation drug discovery initiative based at the SBC and was the Cambridge lead for the Apollo Therapeutics Fund. Iain has been an active trainer for Praxis Courses since 2004.

Mairi Gibbs RTTP

Co-Course Director
Head of Operations, Oxford University Innovation
Dr Mairi Gibbs is Head of Operations at Oxford University Innovation (OUI). A member of OUI’s Strategic Team, she leads OUI’s operational activities across the business, including OUI’s post-deal alliance management function, patent and licence administration team, and information systems. Mairi is responsible for OUI’s process and standard legal documentation. She has particular interests in working with University colleagues to develop the University’s innovation framework to meet current and future needs, and in change management and professional development of technology transfer staff. Mairi is a member of Oxford’s Conflicts of Interest Committee and attends Oxford’s Intellectual Property Advisory Group. She has worked at OUI (formerly Isis Innovation) since 2002, and her extensive practical experience in technology transfer includes formation of spinout companies, licensing, academic outreach, patent portfolio management and prosecution, and management of technology transfer teams. Mairi has a PhD in Chemistry and spent some time in the fine chemicals industry before moving to tech transfer.
Book now